Safety and immunogenicity of heterologous prime-boost immunization with viral-vectored malaria vaccines adjuvanted with Matrix-M™. [electronic resource]
Producer: 20180313Description: 6208-6217 p. digitalISSN:- 1873-2518
- Adenoviridae -- immunology
- Adjuvants, Immunologic -- administration & dosage
- Adolescent
- Adult
- Antibodies, Protozoan -- immunology
- Enzyme-Linked Immunospot Assay -- methods
- Epitopes -- adverse effects
- Female
- Genetic Vectors -- adverse effects
- Humans
- Immunity, Cellular -- immunology
- Immunity, Humoral -- immunology
- Immunization, Secondary -- adverse effects
- Immunogenicity, Vaccine -- immunology
- Immunoglobulin G -- immunology
- Malaria Vaccines -- adverse effects
- Malaria, Falciparum -- immunology
- Male
- Middle Aged
- Nanoparticles -- adverse effects
- Protozoan Proteins -- immunology
- Saponins -- adverse effects
- T-Lymphocytes -- immunology
- Vaccination -- adverse effects
- Vaccinia -- immunology
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.